Release Date: 15/03/24 15:04 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 3.45MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%